메뉴 건너뛰기




Volumn 38, Issue 5, 2013, Pages 523-525

Treatment of Darier disease with oral alitretinoin

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; CHOLESTEROL; EMOLLIENT AGENT; ETRETIN; KERATOLYTIC AGENT; STEROID; TRIACYLGLYCEROL;

EID: 84879219941     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12078     Document Type: Article
Times cited : (37)

References (9)
  • 1
    • 0032902468 scopus 로고    scopus 로고
    • Management of Darier's disease
    • Burge S,. Management of Darier's disease. Clin Exp Dermatol 1999; 24: 53-6.
    • (1999) Clin Exp Dermatol , vol.24 , pp. 53-56
    • Burge, S.1
  • 2
    • 0037282721 scopus 로고    scopus 로고
    • Darier's disease. Epidemiology, pathophysiology, and management
    • Cooper SM, Burge SM,. Darier's disease. Epidemiology, pathophysiology, and management. Am J Clin Dermatol 2003; 4: 97-105.
    • (2003) Am J Clin Dermatol , vol.4 , pp. 97-105
    • Cooper, S.M.1    Burge, S.M.2
  • 3
    • 13944254453 scopus 로고    scopus 로고
    • Dyskeratosis follicularis disease: Case reports and review of the literature
    • Zeglaoui F, Zaraa B, Fazaa B, et al,. Dyskeratosis follicularis disease: case reports and review of the literature. J Eur Acad Dermatol Venereol 2005; 19: 114-17.
    • (2005) J Eur Acad Dermatol Venereol , vol.19 , pp. 114-117
    • Zeglaoui, F.1    Zaraa, B.2    Fazaa, B.3
  • 4
    • 32344448163 scopus 로고    scopus 로고
    • Linear Darier's disease successfully treated with 0, 1% tazarotene gel 'short-contact' therapy
    • Brazzelli V, Prestinari F, Barbagallo T, et al,. Linear Darier's disease successfully treated with 0, 1% tazarotene gel 'short-contact' therapy. Eur J Dermatol 2006; 16: 59-61.
    • (2006) Eur J Dermatol , vol.16 , pp. 59-61
    • Brazzelli, V.1    Prestinari, F.2    Barbagallo, T.3
  • 5
    • 51349123397 scopus 로고    scopus 로고
    • Alitretinoin: A new treatment option for chronic refractory hand eczema
    • Molin S, Ruzicka T,. Alitretinoin: a new treatment option for chronic refractory hand eczema. Hautarzt 2008; 59: 703-9.
    • (2008) Hautarzt , vol.59 , pp. 703-709
    • Molin, S.1    Ruzicka, T.2
  • 6
    • 10344225164 scopus 로고    scopus 로고
    • Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: Results of a randomized, double-blind, placebo-controlled, multicenter trial
    • Ruzicka T, Larsen FG, Galewicz D, et al,. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004; 140: 1453-9.
    • (2004) Arch Dermatol , vol.140 , pp. 1453-1459
    • Ruzicka, T.1    Larsen, F.G.2    Galewicz, D.3
  • 7
    • 40949115877 scopus 로고    scopus 로고
    • Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: Results of a randomized, double-blind, placebo-controlled, multicenter trial
    • Ruzicka T, Lynde CW, Jemec GB, et al,. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicenter trial. Br J Dermatol 2008; 81: 808-17.
    • (2008) Br J Dermatol , vol.81 , pp. 808-817
    • Ruzicka, T.1    Lynde, C.W.2    Jemec, G.B.3
  • 8
    • 77957674549 scopus 로고    scopus 로고
    • Oral alitretinoin in lichen planus: Two case reports
    • Molin S, Ruzicka T,. Oral alitretinoin in lichen planus: two case reports. Acta Derm Venereol 2010; 90: 523-4.
    • (2010) Acta Derm Venereol , vol.90 , pp. 523-524
    • Molin, S.1    Ruzicka, T.2
  • 9
    • 84863112862 scopus 로고    scopus 로고
    • Successful treatment of Darier disease with oral alitretinoin
    • Barnstedt SE,. Successful treatment of Darier disease with oral alitretinoin. Hautarzt 2012; 63: 139-42.
    • (2012) Hautarzt , vol.63 , pp. 139-142
    • Barnstedt, S.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.